1. Home
  2. QNTM vs GIPR Comparison

QNTM vs GIPR Comparison

Compare QNTM & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNTM
  • GIPR
  • Stock Information
  • Founded
  • QNTM 1998
  • GIPR 2015
  • Country
  • QNTM Canada
  • GIPR United States
  • Employees
  • QNTM N/A
  • GIPR N/A
  • Industry
  • QNTM
  • GIPR Real Estate Investment Trusts
  • Sector
  • QNTM
  • GIPR Real Estate
  • Exchange
  • QNTM NYSE
  • GIPR Nasdaq
  • Market Cap
  • QNTM 9.1M
  • GIPR 9.7M
  • IPO Year
  • QNTM N/A
  • GIPR 2021
  • Fundamental
  • Price
  • QNTM $6.23
  • GIPR $1.72
  • Analyst Decision
  • QNTM
  • GIPR Hold
  • Analyst Count
  • QNTM 0
  • GIPR 1
  • Target Price
  • QNTM N/A
  • GIPR N/A
  • AVG Volume (30 Days)
  • QNTM 7.0M
  • GIPR 34.9K
  • Earning Date
  • QNTM 03-31-2025
  • GIPR 04-08-2025
  • Dividend Yield
  • QNTM N/A
  • GIPR 9.07%
  • EPS Growth
  • QNTM N/A
  • GIPR N/A
  • EPS
  • QNTM N/A
  • GIPR N/A
  • Revenue
  • QNTM N/A
  • GIPR $10,215,225.00
  • Revenue This Year
  • QNTM N/A
  • GIPR N/A
  • Revenue Next Year
  • QNTM N/A
  • GIPR $1.14
  • P/E Ratio
  • QNTM N/A
  • GIPR N/A
  • Revenue Growth
  • QNTM N/A
  • GIPR 72.92
  • 52 Week Low
  • QNTM $2.70
  • GIPR $1.50
  • 52 Week High
  • QNTM $70.20
  • GIPR $4.64
  • Technical
  • Relative Strength Index (RSI)
  • QNTM 46.46
  • GIPR 45.65
  • Support Level
  • QNTM $10.68
  • GIPR $1.70
  • Resistance Level
  • QNTM $12.44
  • GIPR $2.06
  • Average True Range (ATR)
  • QNTM 2.41
  • GIPR 0.09
  • MACD
  • QNTM -0.42
  • GIPR 0.00
  • Stochastic Oscillator
  • QNTM 21.66
  • GIPR 17.07

About QNTM QUANTUM BIOPHARMA LTD

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

About GIPR Generation Income Properties Inc.

Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in major markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.

Share on Social Networks: